- Exchange: Vienna
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Trading has been suspended for ICLL:AV
Snapshot for Intercell AG (ICLL)
| Open: | 1.718 | Day's Range: | 1.704 - 1.749 | Volume: | 269,170 |
|---|---|---|---|---|---|
| Previous Close: | 1.730 | 52wk Range: | 1.511 - 2.450 | 1-Yr Rtn: | -28.78% |
Key Statistics for ICLL
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. ATX | - |
| Earnings Per Share (EUR) (ttm) | -0.4900 |
| Est. EPS (EUR) (12/2013) | -0.3230 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 95.47 |
| Shares Outstanding (M) | 55.18 |
| 30 Day Average Volume | 79,755 |
| Price/Book (mrq) | 1.1568 |
| Price/Sale (ttm) | 2.4944 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ICLL
Company Profile & Key Executives for ICLL
Intercell AG is a biotechnology company that develops vaccines for the prevention and treatment of infectious diseases. The Company has developed a vaccine to protect travelers from Japanese encephalitis.
| Thomas LingelbachChairman-Mgmt Board/CEO | Reinhard KanderaCFO/Member-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ICLL News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page